Travaux scientifiques

Doç. Dr. Elif Şenocak Taşçı

39 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Texte intégral en libre accèsSource : OpenAlex

  2. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology

    European Journal of Breast Health, 2026

    DOI 10.4274/ejbh.galenos.2026.2025-10-1 PMID 41873792 Texte intégral en libre accèsSource : OpenAlex

  3. Evaluation of clinicopathological features and prognosis of patients with small cell carcinoma of gastrointestinal system origin.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e16481 Source : OpenAlex

  4. HPV-positive oropharyngeal squamous cell carcinoma: risk-adapted treatment strategies and biomarker-guided individualization

    Oral Oncology, 2026

    DOI 10.1016/j.oraloncology.2026.108005 PMID 42107222 Source : OpenAlex

  5. Risk-adaptive management of stage III NSCLC in the perioperative immunotherapy era: a critical synthesis and clinical framework

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1897546 PMID 42775057 Texte intégral en libre accèsSource : OpenAlex

  6. Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-09707-3 PMID 40653542 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.12033 Source : OpenAlex

  8. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09973-x PMID 41225034 1 citation (Europe PMC) Source : OpenAlex

  9. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic Treatment

    European Journal of Breast Health, 2025

    DOI 10.4274/ejbh.galenos.2025.2025-10-2 PMID 41447641 Texte intégral en libre accèsSource : OpenAlex

  10. Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

    Molecular and Clinical Oncology, 2025

    DOI 10.3892/mco.2025.2846 PMID 40297501 Texte intégral en libre accèsSource : OpenAlex

  11. Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomas

    Frontiers in Oncology, 2025

    DOI 10.3389/fonc.2025.1627452 PMID 41114372 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  12. 115P Changes in surgical and oncological characteristics of early-onset and late-onset colorectal cancers over five-year periods: A single-center 10-year experience

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.05.127 Source : OpenAlex

  13. Predicting Osteoporosis in Elderly Cancer Patients Using the Modified Glasgow Prognostic Index

    Cancer Control, 2025

    DOI 10.1177/10732748251337601 PMID 40265766 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  14. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

    BMC Cancer, 2024

    DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  15. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

    Cancers, 2024

    DOI 10.3390/cancers16122251 PMID 38927957 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  16. Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2337261 PMID 38568074 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  17. BEGEV is an Effective Therapy for Heavily Pretreated and Platinum-Resistant Relapsed/Refractory Hodgkin’s Lymphoma Patients: A Single Center Real-Life Experience

    Indian Journal of Hematology and Blood Transfusion, 2024

    DOI 10.1007/s12288-024-01924-6 PMID 41084559 Texte intégral en libre accèsSource : OpenAlex

  18. Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study

    Cancers, 2024

    DOI 10.3390/cancers16183213 PMID 39335184 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. Cognitive Impairment in Caregivers of Cancer Patients: A Cross-sectional Study

    Acta haematologica oncologica Turcica., 2024

    DOI 10.4274/ahot.galenos.2024.89896 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  20. Assessment of health literacy and HPV knowledge among university students: An observational study

    Medicine, 2024

    DOI 10.1097/md.0000000000039495 PMID 39213230 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  22. Current trends in perioperative treatment of resectable gastric cancer

    World Journal of Gastrointestinal Surgery, 2023

    DOI 10.4240/wjgs.v15.i3.323 PMID 37032791 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  23. Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases

    World Journal of Clinical Cases, 2023

    DOI 10.12998/wjcc.v11.i13.3105 PMID 37215411 Texte intégral en libre accèsSource : OpenAlex

  24. Impact of Professional Seniority on Total Neoadjuvant Treatment Approach for Locally Advanced Rectal Cancer

    Journal of Oncological Sciences, 2023

    DOI 10.37047/jos.2023-96807 Source : OpenAlex

  25. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.4_suppl.202 Source : OpenAlex

  27. Gastrointestinal Sistem Kanserlerinde Güncel Yaklaşımlar Yazarlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.984 Texte intégral en libre accèsSource : OpenAlex

  28. Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?

    Balkan Medical Journal, 2022

    DOI 10.4274/balkanmedj.galenos.2022.2022-6-94 PMID 36317726 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  29. The professional seniority affects the clinical application of total neoadjuvant therapy for locally advanced rectal cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e15590 Source : OpenAlex

  30. The prognostic impact of intramural invasion in patients undergoing surgery for non-metastatic colon cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e15516 Source : OpenAlex

  31. Coronaphobia: A barrier to ongoing cancer treatment?

    Psycho-Oncology, 2022

    DOI 10.1002/pon.5907 PMID 35194885 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  32. Palbociclib Associated Deep Vein Thrombosis: A Case Report

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.59751 Source : OpenAlex

  33. The relationship between PG-SGA scores and nutritional status of patients receiving chemotherapy

    Progress in nutrition, 2022

    DOI 10.23751/pn.v24i4.12806 Source : OpenAlex

  34. The Role of Gene Signatures on Treatment Decisions in Early-Stage Breast Cancer

    Acta Oncologica Turcica, 2021

    DOI 10.5505/aot.2021.46693 Source : OpenAlex

  35. Which One Causes More Anxiety: Pandemic or Cancer?

    Research Square, 2021

    DOI 10.21203/rs.3.rs-721903/v1 Texte intégral en libre accèsSource : OpenAlex

  36. Real world effıcacy and safety data of immune checkpoint inhibitors in Turkish patients witlı metastatic melanoma: a Turkish oncology group retrospect study.

    Source : page de profil sur acibadem.com.tr

  37. Real-world efficacy and safety of fırst-line nivolumab plus chemotherapy in patients with advanced gastric, gastroesophageal junction, and esophageal esophageal adenocarcinoma: a nationwide observational Turkish Oncology Group (TOG) study.

    Source : page de profil sur acibadem.com.tr

  38. Turkish adaptation of QEQ-SH22 quality of sexual life assessment scale in cancer patients - validity and reliability study

    Source : page de profil sur acibadem.com.tr

  39. Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).

    Source : page de profil sur acibadem.com.tr